Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Sunitinib & Pancreatic neuroendocrine tumors (PanNETs / PETs / PNETs), on May 20, 2011, the US Food and Drug Administration (FDA) approved sunitinib malate capsules for the treatment of progressive, well-differentiated Pancreatic neuroendocrine tumors (PanNETs / PETs / PNETs) in patients with unresectable locally advanced or metastatic disease (1).
There is an EMA approval of sunitinib in Europe (2, 3).
The clinical phase III trial NCT00428597, which was multinational, randomized, d…